Cleared Special

K221339 - Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection (FDA 510(k) Clearance)

Jun 2022
Decision
31d
Days
Class 2
Risk

K221339 is an FDA 510(k) clearance for the Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection. This device is classified as a Catheter, Angioplasty, Peripheral, Transluminal (Class II - Special Controls, product code LIT).

Submitted by Contego Medical, Inc. (Raleigh, US). The FDA issued a Cleared decision on June 9, 2022, 31 days after receiving the submission on May 9, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250.

Submission Details

510(k) Number K221339 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2022
Decision Date June 09, 2022
Days to Decision 31 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code LIT - Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250

Similar Devices - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 9
Armada™ 14 NC PTA Catheter
K252512 · Abbott Medical · Feb 2026
Passeo-35 Xeo Peripheral Dilatation Catheter
K250706 · Biotronik, Inc. · Apr 2025
Oscar Peripheral Multifunctional Catheter system
K241711 · Biotronik, Inc. · Jul 2024
Sterling™ MONORAIL™ PTA Balloon Dilatation Catheter (H74939031404020 )
K241683 · Boston Scientific Corporation · Jul 2024
Passeo-35 Xeo Peripheral Dilatation Catheter
K222065 · Biotronik, Inc. · Feb 2023
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023